This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n4http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q81838930
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel im Juni 2005 veröffentlichter wissenschaftlicher Artikel article scientifique publié en 2005 artículu científicu espublizáu en xunu de 2005 наукова стаття, опублікована в червні 2005 scientific article published on 01 June 2005
p:P577
wds:Q81838930-2C047B88-3F4B-4EFF-9D69-40A9E0073393
wdt:P577
2005-06-01T00:00:00Z
p:P2093
wds:Q81838930-63917C34-C76C-4BD6-B3C0-E1D76B9D71EE
wdt:P2093
Bart C J M Fauser
rdfs:label
Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?
skos:prefLabel
Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?
schema:name
Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?
p:P50
wds:Q81838930-8727854D-057E-44B4-9374-F5228D98A096
wdt:P50
wd:Q7150251
p:P1476
wds:Q81838930-08F80D84-AB80-4107-8774-0CAC97D2A29F
wdt:P1476
Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?
p:P304
wds:Q81838930-C3172127-5448-4E3C-9B02-4A0D05BECA54
wdt:P304
1607-1611
p:P31
wds:Q81838930-BD43A843-E41E-4BD2-BCED-5F9D8B0E4C03
wdt:P31
wd:Q13442814
p:P698
wds:Q81838930-50A80425-D73C-4448-AE8E-B70FEF805607
wdtn:P698
n12:15950626
wdt:P698
15950626
p:P1433
wds:Q81838930-6F765862-F03C-4705-A7C3-AD3269585098
wdt:P1433
wd:Q15724525
p:P433
wds:Q81838930-35BEA083-C6AE-4D31-B33E-1078D3386BEE
p:P478
wds:Q81838930-1E094D2A-3496-4F96-AD0D-7DFEF036CFEC
wdt:P433
6
wdt:P478
83
p:P356
wds:Q81838930-795E67D0-78CA-4062-B3C6-BAEEB423C0E7
wdtn:P356
n4:J.FERTNSTERT.2005.02.011
wdt:P356
10.1016/J.FERTNSTERT.2005.02.011